Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Guangdong Key Laboratory of Urology, Guangzhou, Guangdong, China.
World J Urol. 2023 Jun;41(6):1647-1652. doi: 10.1007/s00345-023-04391-2. Epub 2023 Apr 8.
To identify the clinical characteristics of patients who underwent superselective renal arterial embolization (SRAE) after percutaneous nephrolithotomy (PCNL) and to explore the risk factors for failed initial SRAE after PCNL.
Patients who underwent SRAE for severe haemorrhage following PCNL between January 2014 and December 2020 were included in the study. The clinical data of those patients and the parameters and characteristics of the perioperative PCNL and SRAE procedures were collected and analysed.
A total of 243 patients were included in this study. A total of 139 patients (57.2%) had a pseudoaneurysm, 25 (10.3%) had an arteriovenous fistula, 50 (20.6%) patients had both a pseudoaneurysm and an arteriovenous fistula, and 29 (11.9%) had an arterial laceration. In 177 patients with single percutaneous access, 125 (70.6%) patients exhibited nontract haemorrhage, and 55 (31.1%) patients exhibited multiple bleeding sites. In 66 patients with multiple percutaneous access, 44 (66.7%) patients exhibited nontract haemorrhage, and 32 (48.5%) patients exhibited multiple bleeding sites. The decrease in Hb before SRAE was 41.4 ± 19.8 g/L. The mean time between PCNL surgery and initial SRAE was 6.4 ± 4.9 days. Serum creatinine was increased after the SRAE procedure. Initial SRAE was successful in 229 (94.2%) patients and failed in 14 (5.8%) patients. Multivariate regression demonstrated that hydronephrosis < 20 mm, total ultrasonographic guidance, solitary kidney, previous ipsilateral renal surgery, PCNL duration > 90 min and multiple bleeding sites were potential risk factors for initial embolization failure.
Percutaneous access was not the most important reason for post-PCNL severe haemorrhage. SRAE is effective for the treatment of severe haemorrhage following PCNL; however, several factors have an impact on the success of initial SRAE. Additionally, the SRAE procedure may affect renal function.
确定经皮肾镜碎石取石术后行超选择性肾动脉栓塞术(SRAE)患者的临床特征,并探讨经皮肾镜碎石取石术后初始 SRAE 失败的危险因素。
纳入 2014 年 1 月至 2020 年 12 月期间因经皮肾镜碎石取石术后严重出血而行 SRAE 的患者。收集并分析这些患者的临床资料,以及围手术期经皮肾镜碎石取石术和 SRAE 手术的参数和特征。
本研究共纳入 243 例患者。其中,139 例(57.2%)患者为假性动脉瘤,25 例(10.3%)患者为动静脉瘘,50 例(20.6%)患者同时存在假性动脉瘤和动静脉瘘,29 例(11.9%)患者为动脉撕裂。在 177 例单次经皮肾镜穿刺的患者中,125 例(70.6%)患者表现为非通道性出血,55 例(31.1%)患者表现为多个出血部位。在 66 例多次经皮肾镜穿刺的患者中,44 例(66.7%)患者表现为非通道性出血,32 例(48.5%)患者表现为多个出血部位。SRAE 前 Hb 下降 41.4±19.8 g/L。PCNL 术后至首次 SRAE 的平均时间为 6.4±4.9 天。SRAE 术后血清肌酐升高。229 例(94.2%)患者的首次 SRAE 成功,14 例(5.8%)患者的首次 SRAE 失败。多因素回归分析表明,肾积水<20mm、全超声引导、孤立肾、同侧肾脏手术史、PCNL 时间>90min 和多个出血部位是初始栓塞失败的潜在危险因素。
经皮肾镜穿刺不是经皮肾镜碎石取石术后严重出血的最重要原因。SRAE 治疗经皮肾镜碎石取石术后严重出血是有效的,但有几个因素会影响初始 SRAE 的成功率。此外,SRAE 手术可能会影响肾功能。